Preliminary reports point out conolidine may inhibit specific ion channels, reducing neuronal excitability and limiting pain indicators. This mechanism is particularly suitable in neuropathic suffering, wherever abnormal signaling results in persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to pain perception. https://josephf261fas1.wikifrontier.com/user